• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5072464)   Today's Articles (0)
For: Heerspink HJ, Provenzano M, Vart P, Jongs N, Correa-Rotter R, Rossing P, Mark PB, Pecoits-Filho R, McMurray JJ, Langkilde AM, Wheeler DC, Toto RB, Chertow GM. Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria. Am Heart J 2024;270:125-135. [PMID: 38367893 DOI: 10.1016/j.ahj.2024.02.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/12/2024] [Revised: 02/12/2024] [Accepted: 02/12/2024] [Indexed: 02/19/2024]
Number Cited by Other Article(s)
1
Nielsen SF, Duus CL, Buus NH, Bech JN, Mose FH. The effects of empagliflozin on systemic haemodynamic function: three randomized, placebo-controlled trials. J Hypertens 2025;43:1021-1029. [PMID: 40156337 DOI: 10.1097/hjh.0000000000004007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2024] [Accepted: 03/04/2025] [Indexed: 04/01/2025]
2
Lutnik M, Weisshaar S, Litschauer B, Bayerle-Eder M, Niederdöckl J, Wolzt M. Dapagliflozin prevents vascular ischemia-reperfusion injury in healthy young males: a randomized, placebo-controlled, double-blinded trial. Sci Rep 2025;15:16633. [PMID: 40360700 PMCID: PMC12075666 DOI: 10.1038/s41598-025-01405-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2025] [Accepted: 05/06/2025] [Indexed: 05/15/2025]  Open
3
Minutolo R, Borrelli S, Ambrosini A, Amoroso L, Aucella F, Batini V, Battaglia Y, Bregoli L, Cantaluppi V, Cianciolo G, Conti P, Fabbrini P, Giammarresi C, Imbalzano E, La Rosa S, Marengo M, Montinaro V, Musone D, Napoli M, Nappi F, Pluvio C, Santoro D, Scarpioni R, Sopranzi F, Tullio T, De Nicola L. Efficacy and safety of dapagliflozin in patients with CKD: real-world experience in 93 Italian renal clinics. Clin Kidney J 2025;18:sfae396. [PMID: 39834621 PMCID: PMC11744308 DOI: 10.1093/ckj/sfae396] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2024] [Indexed: 01/22/2025]  Open
4
Nielsen SF, Duus CL, Buus NH, Bech JN, Mose FH. Randomized, Placebo-Controlled Trial on the Renal and Systemic Hemodynamic Effects of Empagliflozin. Kidney Int Rep 2025;10:134-144. [PMID: 39810756 PMCID: PMC11725969 DOI: 10.1016/j.ekir.2024.10.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2024] [Revised: 09/27/2024] [Accepted: 10/21/2024] [Indexed: 01/16/2025]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA